Skip to main content
. 2020 Sep 20;80(17):1751–1761. doi: 10.1007/s40265-020-01402-z

Fig. 1.

Fig. 1

Schematic representation of the complex sepsis pathway and various targets of currently investigated drug candidates.

Adapted from Azeredo da Silveira S, Shorr AF. Critical parameters for the development of novel therapies for severe and resistant infections-A case study on CAL02, a non-traditional broad-spectrum anti-virulence drug. Antibiotics (Basel). 2020;9(2):94